## Opioid Pharmacokinetics in Acute Pain Management **Key Point:** Remifentanil is an ultra-short-acting synthetic opioid with a duration of action of 3–5 minutes, making it ideal for acute perioperative pain control. ### Mechanism of Rapid Offset Remifentanil is rapidly metabolized by non-specific plasma and tissue esterases, independent of hepatic or renal function. This unique pharmacokinetic profile allows for: - Rapid onset (1–3 minutes) - Predictable offset within minutes of discontinuation - No active metabolites - Minimal accumulation with repeated dosing ### Comparison of Opioid Durations | Opioid | Duration of Action | Route | Clinical Use | |--------|-------------------|-------|---------------| | Remifentanil | 3–5 minutes | IV only | Acute perioperative pain, intraoperative analgesia | | Morphine | 3–4 hours | IV/IM/PO | Moderate to severe acute and chronic pain | | Methadone | 24–36 hours | PO/IV | Chronic pain, opioid maintenance therapy | | Buprenorphine | 6–8 hours | IV/IM/SL | Moderate pain, opioid-induced respiratory depression reversal | **High-Yield:** Remifentanil's ester linkage makes it unique among synthetic opioids — it is the only one susceptible to rapid plasma esterase hydrolysis. **Clinical Pearl:** Remifentanil is used exclusively in intraoperative settings and intensive care units because its short duration requires continuous infusion; it cannot be used for postoperative analgesia once the infusion is stopped. **Warning:** Remifentanil is NOT suitable for chronic pain management or oral administration — it must be given intravenously as a continuous infusion. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.